Telescope Innovations（TELI.F）株式概要Telescope Innovations Corp.は化学技術会社で、米国とカナダの製薬・化学業界向けに製造プロセスやツールを開発している。 詳細TELI.F ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6リスク分析US市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去1年間で株主の希薄化は大幅に進んだ キャッシュランウェイが1年未満である 意味のある時価総額がありません ( $28M )すべてのリスクチェックを見るTELI.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW463,909 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA463,909 investors already sharing narrativesYour Fair ValueUS$Current PriceUS$0.418.7% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-6m55m2016201920222025202620282031Revenue CA$54.8mEarnings CA$7.0mAdvancedSet Fair ValueView all narrativesTelescope Innovations Corp. 競合他社RadnostixSymbol: OTCPK:INISMarket cap: US$33.9mHarvard BioscienceSymbol: NasdaqCM:HBIOMarket cap: US$34.4mBioqualSymbol: OTCPK:BIOQMarket cap: US$29.1mCircle8 GroupSymbol: NasdaqGM:CIRCMarket cap: US$54.0m価格と性能株価の高値、安値、推移の概要Telescope Innovations過去の株価現在の株価CA$0.4152週高値CA$0.7752週安値CA$0.21ベータ1.331ヶ月の変化33.83%3ヶ月変化-25.71%1年変化58.02%3年間の変化118.05%5年間の変化n/aIPOからの変化-12.58%最新ニュースお知らせ • Aug 20Telescope Innovations Corp. Announces Appointment of Dr. E. Neil Lewis to the Board of Directors, Effective August 19, 2026Telescope Innovations Corp. announced the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by the NIH in 1992 holding the position of Senior Biophysical Researcher. He is a Fellow of the Royal Society of Chemistry (FRSC) and a Chartered Chemist (CChem) also conferred by the Royal Society of Chemistry. He is also a Fellow of the Society of Applied Spectroscopy. Dr. Lewis was the founder or co-founder and CEO of three technology companies, including Spectral Dimensions Inc., a company that developed chemical imaging systems for use by the pharmaceutical and other industries. He has authored more than 100 peer reviewed papers and book chapters and is the holder of numerous patents for other novel technologies currently in use by the analytical industry.お知らせ • Jul 16Telescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirementsお知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.最新情報をもっと見るRecent updatesお知らせ • Aug 20Telescope Innovations Corp. Announces Appointment of Dr. E. Neil Lewis to the Board of Directors, Effective August 19, 2026Telescope Innovations Corp. announced the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by the NIH in 1992 holding the position of Senior Biophysical Researcher. He is a Fellow of the Royal Society of Chemistry (FRSC) and a Chartered Chemist (CChem) also conferred by the Royal Society of Chemistry. He is also a Fellow of the Society of Applied Spectroscopy. Dr. Lewis was the founder or co-founder and CEO of three technology companies, including Spectral Dimensions Inc., a company that developed chemical imaging systems for use by the pharmaceutical and other industries. He has authored more than 100 peer reviewed papers and book chapters and is the holder of numerous patents for other novel technologies currently in use by the analytical industry.お知らせ • Jul 16Telescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirementsお知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.お知らせ • Feb 05Telescope Innovations Corp. announced that it expects to receive CAD 3 million in fundingTelescope Innovations Corp. announced a non-brokered private placement of 7,500,000 units at a price of CAD 0.40 per unit for the gross proceeds of CAD 3,000,000 on February 4, 2025. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase an additional common share at a price of CAD 0.75 for a period of thirty-six months. In connection with closing of the Offering, the Company may pay finders’ fees to eligible parties who have assisted in introducing subscribers to the Offering. Completion of the Offering remains subject to regulatory approval.お知らせ • Jan 16Telescope Innovations Corp. Announces the Successful Outcomes of Its Brine-To-Battery ProgramTelescope Innovations Corp. announced the successful outcomes of its Brine-to-Battery Program. Over the past year, Telescope Innovations' proprietary ReCRFTTM recrystallization technology has produced battery-grade (>99% pure) lithium carbonate from a wide variety of North American lithium-containing brines. Direct Lithium Extraction (DLE) eluates were obtained from various producers with lithium brine projects across Canada and the US. Isolating dilute lithium from low-grade brine resources in North America traditionally requires several processing steps and additional reagents, resulting in prohibitive CAPEX and OPEX costs relative to overseas operations. Telescope Innovations' ReCRFTTM collapses the lithium carbonate refining flow sheet, reducing these costs to enable a sustainable, on-shore supply of battery raw materials. ReCRFTTM advantages include: 1. Elimination of polishing steps: Lithium carbonate can be produced directly from DLE concentrates, without traditional feed polishing steps. This reduces reagent, plant equipment, energy, and operating costs. A high tolerance for feed variability: Through the Company's Brine-to-Battery program, ReCRFTTM has demonstrated the production of >99% pure lithium carbonate from eight brine sources, originating from Alberta, Texas, Nevada, and Arkansas, and ranging in original lithium purity from 15% - 93% (Figure 1, bottom). Telescope Innovations has protected ReCRFTTM technology through a patent application under the Patent Cooperation Treaty and additional jurisdictions.お知らせ • Feb 16+ 1 more updateTelescope Innovations Corp. Appoints Henry Dubina as CEOTelescope Innovations Corp. appointed Henry Dubina as Chief Executive Officer. Mr. Dubina brings significant experience to Telescope, having served in General Management positions in the scientific instruments industry for the past 35 years. He served as President and Head of Mettler-Toledo AutoChem for over 20 years, directing the global business from its infancy to global market leadership. Mettler-Toledo Autochem provides technology solutions and services to speed the development of high value, chemical-based processes. AutoChem instruments have been ubiquitously deployed in academia and industry for biopharmaceutical, chemical, and advanced materials applications to boost R&D productivity.お知らせ • Feb 13Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024.お知らせ • Jan 24Telescope Innovations Corp. Files Provisional Patent ApplicationTelescope Innovations Corp. announced it has filed a provisional patent application (63/606,069) on a disruptive new technique to purify lithium carbonate, a critical mineral building block for lithium ion battery production and particularly for low-cost LFP battery chemistries. This is Telescope's second application related to processing battery raw materials, the first of which provides a low-temperature method for generating lithium sulfide. The current provisional application describes a single-step process that produces battery-grade, >99.9% lithium carbonate from crude material of 20-95% purity. This technology can dramatically reduce the requirement for pre-processing of crude lithium brine feeds, which conventionally accounts for up to 80% of refinement costs.株主還元TELI.FUS Life SciencesUS 市場7D32.5%5.3%-2.1%1Y58.0%28.1%18.8%株主還元を見る業界別リターン: TELI.F過去 1 年間で28.1 % の収益を上げたUS Life Sciences業界を上回りました。リターン対市場: TELI.F過去 1 年間で18.8 % の収益を上げたUS市場を上回りました。価格変動Is TELI.F's price volatile compared to industry and market?TELI.F volatilityTELI.F Average Weekly Movement16.5%Life Sciences Industry Average Movement7.8%Market Average Movement7.2%10% most volatile stocks in US Market16.3%10% least volatile stocks in US Market3.1%安定した株価: TELI.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: TELI.Fの weekly volatility ( 16% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aHenry Dubinatelescopeinnovations.comTelescope Innovations Corp.は化学技術会社で、米国とカナダの製薬・化学業界向けに製造プロセスやツールを開発している。同社はファイザー社、スタンダード・リチウム社と研究提携し、高純度硫化リチウムの製造方法を開発している。Telescope Innovations Corp.はカナダのバンクーバーを拠点としている。もっと見るTelescope Innovations Corp. 基礎のまとめTelescope Innovations の収益と売上を時価総額と比較するとどうか。TELI.F 基礎統計学時価総額US$28.47m収益（TTM）-US$2.97m売上高(TTM)US$5.30m6.5xP/Sレシオ-11.7xPER（株価収益率TELI.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計TELI.F 損益計算書（TTM）収益CA$7.30m売上原価CA$0売上総利益CA$7.30mその他の費用CA$11.39m収益-CA$4.09m直近の収益報告May 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.051グロス・マージン100.00%純利益率-56.03%有利子負債／自己資本比率14.7%TELI.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 23:05終値2026/08/21 00:00収益2026/05/31年間収益2025/08/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Telescope Innovations Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 20Telescope Innovations Corp. Announces Appointment of Dr. E. Neil Lewis to the Board of Directors, Effective August 19, 2026Telescope Innovations Corp. announced the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by the NIH in 1992 holding the position of Senior Biophysical Researcher. He is a Fellow of the Royal Society of Chemistry (FRSC) and a Chartered Chemist (CChem) also conferred by the Royal Society of Chemistry. He is also a Fellow of the Society of Applied Spectroscopy. Dr. Lewis was the founder or co-founder and CEO of three technology companies, including Spectral Dimensions Inc., a company that developed chemical imaging systems for use by the pharmaceutical and other industries. He has authored more than 100 peer reviewed papers and book chapters and is the holder of numerous patents for other novel technologies currently in use by the analytical industry.
お知らせ • Jul 16Telescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").
お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.
お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.
お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirements
お知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.
お知らせ • Aug 20Telescope Innovations Corp. Announces Appointment of Dr. E. Neil Lewis to the Board of Directors, Effective August 19, 2026Telescope Innovations Corp. announced the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026. Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by the NIH in 1992 holding the position of Senior Biophysical Researcher. He is a Fellow of the Royal Society of Chemistry (FRSC) and a Chartered Chemist (CChem) also conferred by the Royal Society of Chemistry. He is also a Fellow of the Society of Applied Spectroscopy. Dr. Lewis was the founder or co-founder and CEO of three technology companies, including Spectral Dimensions Inc., a company that developed chemical imaging systems for use by the pharmaceutical and other industries. He has authored more than 100 peer reviewed papers and book chapters and is the holder of numerous patents for other novel technologies currently in use by the analytical industry.
お知らせ • Jul 16Telescope Innovations Corp. Announces Resignation of Ali Pejman as Board of Directors, Effective 14 July 2026Telescope Innovations Corp. announced that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective 14 July 2026. Mr. Pejman will remain engaged as a consultant to the Company, pursuant to a consulting agreement to be entered into shortly after Mr. Pejman's resignation. The Board continues to actively search for a qualified candidate to fill the resulting vacancy and will announce the appointment of a successor in due course, in accordance with applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE").
お知らせ • Apr 07Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026Telescope Innovations Corp., Annual General Meeting, Jun 15, 2026.
お知らせ • Oct 15Telescope Innovations Corp. announced that it has received CAD 6.5 million in fundingOn October 14, 2025, the Telescope Innovations Corp closed the transaction by issuing 5,186,816 common shares of the company at a price CAD 0.25 for the proceeds of CAD 1,296,704 in second and final tranche. A finder’s fee in the amount of CAD 3,500 has been paid by the Company.
お知らせ • Jul 04Telescope Innovations Corp. announced that it expects to receive CAD 5 million in fundingTelescope Innovations Corp announced a non-brokered private placement of 20,000,000 shares at issue price CAD 0.25 per share for gross proceeds CAD 5,000,000 on July 3, 2025. The transaction is subject to compliance with applicable regulatory requirements
お知らせ • Feb 24Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025Telescope Innovations Corp., Annual General Meeting, Apr 23, 2025.
お知らせ • Feb 05Telescope Innovations Corp. announced that it expects to receive CAD 3 million in fundingTelescope Innovations Corp. announced a non-brokered private placement of 7,500,000 units at a price of CAD 0.40 per unit for the gross proceeds of CAD 3,000,000 on February 4, 2025. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase an additional common share at a price of CAD 0.75 for a period of thirty-six months. In connection with closing of the Offering, the Company may pay finders’ fees to eligible parties who have assisted in introducing subscribers to the Offering. Completion of the Offering remains subject to regulatory approval.
お知らせ • Jan 16Telescope Innovations Corp. Announces the Successful Outcomes of Its Brine-To-Battery ProgramTelescope Innovations Corp. announced the successful outcomes of its Brine-to-Battery Program. Over the past year, Telescope Innovations' proprietary ReCRFTTM recrystallization technology has produced battery-grade (>99% pure) lithium carbonate from a wide variety of North American lithium-containing brines. Direct Lithium Extraction (DLE) eluates were obtained from various producers with lithium brine projects across Canada and the US. Isolating dilute lithium from low-grade brine resources in North America traditionally requires several processing steps and additional reagents, resulting in prohibitive CAPEX and OPEX costs relative to overseas operations. Telescope Innovations' ReCRFTTM collapses the lithium carbonate refining flow sheet, reducing these costs to enable a sustainable, on-shore supply of battery raw materials. ReCRFTTM advantages include: 1. Elimination of polishing steps: Lithium carbonate can be produced directly from DLE concentrates, without traditional feed polishing steps. This reduces reagent, plant equipment, energy, and operating costs. A high tolerance for feed variability: Through the Company's Brine-to-Battery program, ReCRFTTM has demonstrated the production of >99% pure lithium carbonate from eight brine sources, originating from Alberta, Texas, Nevada, and Arkansas, and ranging in original lithium purity from 15% - 93% (Figure 1, bottom). Telescope Innovations has protected ReCRFTTM technology through a patent application under the Patent Cooperation Treaty and additional jurisdictions.
お知らせ • Feb 16+ 1 more updateTelescope Innovations Corp. Appoints Henry Dubina as CEOTelescope Innovations Corp. appointed Henry Dubina as Chief Executive Officer. Mr. Dubina brings significant experience to Telescope, having served in General Management positions in the scientific instruments industry for the past 35 years. He served as President and Head of Mettler-Toledo AutoChem for over 20 years, directing the global business from its infancy to global market leadership. Mettler-Toledo Autochem provides technology solutions and services to speed the development of high value, chemical-based processes. AutoChem instruments have been ubiquitously deployed in academia and industry for biopharmaceutical, chemical, and advanced materials applications to boost R&D productivity.
お知らせ • Feb 13Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024Telescope Innovations Corp., Annual General Meeting, Apr 18, 2024.
お知らせ • Jan 24Telescope Innovations Corp. Files Provisional Patent ApplicationTelescope Innovations Corp. announced it has filed a provisional patent application (63/606,069) on a disruptive new technique to purify lithium carbonate, a critical mineral building block for lithium ion battery production and particularly for low-cost LFP battery chemistries. This is Telescope's second application related to processing battery raw materials, the first of which provides a low-temperature method for generating lithium sulfide. The current provisional application describes a single-step process that produces battery-grade, >99.9% lithium carbonate from crude material of 20-95% purity. This technology can dramatically reduce the requirement for pre-processing of crude lithium brine feeds, which conventionally accounts for up to 80% of refinement costs.
